Table 1.
MI patient characteristics
| Variable | Value |
|---|---|
|
| |
| Age (years) | 62.9 ± 8.6 |
| Males, n | 76 (82.6%) |
| BMI (kg/m2) | 24.58 ± 3.02 |
| Hypertension, n | 68 (73.9%) |
| Diabetes, n | 31 (33.7%) |
| Hyperlipidemia, n | 11 (12.0%) |
| COPD, n | 2 (2.2%) |
| History of angina pectoris, n | 74 (80.4%) |
| Stenosis vessel number, n | 2.51 ± 0.70 |
| CCS class | 1.53 ± 1.04 |
| NYHA class | 1.85 ± 1.13 |
| LVEDVi (ml/m2) | 72.83 ± 35.94 |
| LVESVi (ml/m2) | 42.68 ± 35.13 |
| LVEF (%) | 47.91 ± 15.88 |
| STS | 8.5 (1.3–18.8) |
| TPD (%) | 16.41 ± 14.20 |
| Viable myocardium (%) | 6 (2–11.8) |
| Scar (%) | 5 (2–9.8) |
| Reduced thickening segments/normal perfusion segments (%) | 9.55 (0.00–36.46) |
| Reduced thickening segments/decreased perfusion segments (%) | 66.67 (20.00–100.00) |
MI, Myocardial infarction; BMI, body mass index; COPD, chronic obstructive pulmonary disease; CCS, Canadian class classification of angina pectoris; NYHA, New York Heart Association classification of heart failure; LVEDVi, left ventricular end-diastolic volume index; LVESVi, left ventricular end-systolic volume index; LVEF, left ventricular ejection fraction; STS, summed thickening score; TPD, total perfusion deficit